Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced and Relapsed Solid Tumors”

189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 189 results

Early research (Phase 1)Study completedNCT01051635
What this trial is testing

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)UnknownNCT05320640
What this trial is testing

Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors

Who this might be right for
Relapsed/Refractory Non-Hodgkin LymphomaAdvanced Solid Tumors
Chinese PLA General Hospital 100
Early research (Phase 1)Looking for participantsNCT05892718
What this trial is testing

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Who this might be right for
Advanced Solid TumorRefractory Non-Hodgkin Lymphoma
FBD Biologics Limited 80
Early research (Phase 1)Study completedNCT05040932
What this trial is testing

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Who this might be right for
Cancer
Eucure (Beijing) Biopharma Co., Ltd 8
Early research (Phase 1)Study completedNCT04836195
What this trial is testing

Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

Who this might be right for
B-cell Non Hodgkin LymphomaAdvanced Solid Tumor
Pacylex Pharmaceuticals 29
Early research (Phase 1)Ended earlyNCT05904236
What this trial is testing

Safety and Tolerability of Intravenous Administration of ICVB-1042

Who this might be right for
Patients With Advanced Solid Tumors
IconOVir Bio 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05052255
What this trial is testing

RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Ryvu Therapeutics SA 120
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT05631886
What this trial is testing

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Who this might be right for
Solid Tumor, AdultLymphomaEphA2 Overexpression+4 more
Chinese PLA General Hospital 10
Early research (Phase 1)Study completedNCT04659629
What this trial is testing

NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer

Who this might be right for
Solid TumorAdvanced Solid Tumor
Neurogene Inc. 59
Early research (Phase 1)Study completedNCT03884556
What this trial is testing

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Who this might be right for
Solid TumorLymphoma
Trishula Therapeutics, Inc. 56
Early research (Phase 1)Study completedNCT02482441
What this trial is testing

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

Who this might be right for
Advanced Relapsed TumorsRefractory Solid Tumors
OncoMed Pharmaceuticals, Inc. 50
Early research (Phase 1)Study completedNCT02225002
What this trial is testing

Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Ended earlyNCT03690154
What this trial is testing

Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML

Who this might be right for
Advanced CancerSolid TumorsAcute Myeloid Leukemia Refractory+1 more
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 67
Early research (Phase 1)Study completedNCT01495663
What this trial is testing

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned

Who this might be right for
Cancer
Cellectar Biosciences, Inc. 12
Early research (Phase 1)Looking for participantsNCT05607199
What this trial is testing

A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

Who this might be right for
Solid Tumor, AdultAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Aurigene Discovery Technologies Limited 80
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT00741403
What this trial is testing

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMetastatic CancerLymphoma+2 more
Cornerstone Pharmaceuticals 39
Load More Results